12.00 - 13.00
Lunch
13.00 - 13.30
Introduction and welcome - what have we achived since we established the Nordic ITP group?
// Waleed Ghanima
13.30 - 15.00
Future collaborative research
Chair: // Stella Wei
Moving ahead with research in the Nordic
// Henrik Frederiksen
Discussions; set-up and funding
// All
A univerisal research registry for ITP: is it possible?
// Waleed Ghanima
Abstract: Predcting the effect of Rituximab: data from the Nordic chronic ITP registry
// Galina Tsykunova
Abstract: Abstract: HRQoL in ITP
// Riccardo Tomasselo
Study proposal: Evaluation of cardiovascular risk in patients with ITP and use of antiagregative/anticoagulant medication
// Nora Butta
15.00 - 15.30
Break
15.30 - 17.30
Clinical update and treatment
Chair: // Terhi Friman
Management of ITP - current and future therapies
// Cecilia Karlström
Real world data on TPO-RA and fostamatinib - how to generate such data in the nordics
// Waleed Ghanima
Highlights from ASH: the results of rilzabrutimib study
// Waleed Ghanima
Update on ongoing study: The Holistic study
// Eirik Tjønnfjord
New study proporsal: TPO-stop study
// Henrik Frederiksen
Abstract: Efficacy and safety of daratumumab in ITP - results of the Dart study
// Galina Tsykunova
Abstract: Age-driven and disease-specific alterations in platelets in ITP
// Nora Butta
19.00 Dinner (Restaurant located on the top floor)